Search research articles
Contact Us
Filters
Showing results (151-160 of 609) with videos related to
Page
of 61
Sort By:
Internal and Emergency Medicine
|
May 23, 2024
A case of lymphadenopathies with concomitant multiple acquired hemostasis disorders in an adult female patient
Addolorata Truma, Andrea Artoni, Juri Alessandro Giannotta, et al.
Journal of Thrombosis and Thrombolysis
|
March 28, 2012
Case report: use of thienopyridines in a patient with acquired idiopathic thrombotic thrombocytopenic purpura
Luca A Lotta, Ilaria Mancini, Giacomo Tuana, et al.
Blood Cells, Molecules & Diseases
|
September 18, 2012
Drop of residual plasmatic activity of ADAMTS13 to undetectable levels during acute disease in a patient with adult-onset congenital thrombotic thrombocytopenic purpura
Luca A Lotta, Haifeng M Wu, Andrea Cairo, et al.
Haematologica
|
October 15, 2020
Dramatic presentation of acquired thombotic thrombocytopenic purpura associated with COVID-19
Marco Capecchi, Cristina Mocellin, Chiara Abbruzzese, et al.
Haematologica
|
April 12, 2003
Patients with localized and disseminated tumors have reduced but measurable levels of ADAMTS-13 (von Willebrand factor cleaving protease)
Pier Mannuccio Mannucci, Mehran Karimi, Ahmad Mosalaei, et al.
Thrombosis Research
|
May 27, 2015
Molecular characterization of 7 patients affected by dys- or hypo-dysfibrinogenemia: Identification of a novel mutation in the fibrinogen Bbeta chain causing a gain of glycosylation
Rosanna Asselta, Michela Robusto, Manuela Platé, et al.
Clinical Pharmacology and Therapeutics
|
March 6, 2004
CYP2C9 genotypes and dose requirements during the induction phase of oral anticoagulant therapy
Flora Peyvandi, Marta Spreafico, Simona Maria Siboni, et al.
Thrombosis Research
|
April 22, 2015
How the direct oral anticoagulant apixaban affects thrombin generation parameters
Armando Tripodi, Lidia Padovan, Chantarangkul Veena, et al.
Journal of Clinical Medicine Research
|
November 10, 2025
A Challenging Case of Immune-Related Organizing Pneumonitis Following Programmed Cell Death 1 Inhibitor Therapy in Non-Small Cell Lung Cancer
Giovanni Paolozzi, Roberta Gualtierotti, Raffaella Rossio, et al.
Journal of Thrombosis and Haemostasis : JTH
|
June 12, 2025
The genetic spectrum of rare bleeding disorders
Samin Mohsenian, Omid Seidizadeh, Andrea Cairo, et al.
Page
of 61
Search research articles
Search
Showing results (151-160 of 609) with videos related to
Sort By:
Page
of 61
Internal and Emergency Medicine
|
May 23, 2024
A case of lymphadenopathies with concomitant multiple acquired hemostasis disorders in an adult female patient
Addolorata Truma, Andrea Artoni, Juri Alessandro Giannotta, et al.
Journal of Thrombosis and Thrombolysis
|
March 28, 2012
Case report: use of thienopyridines in a patient with acquired idiopathic thrombotic thrombocytopenic purpura
Luca A Lotta, Ilaria Mancini, Giacomo Tuana, et al.
Blood Cells, Molecules & Diseases
|
September 18, 2012
Drop of residual plasmatic activity of ADAMTS13 to undetectable levels during acute disease in a patient with adult-onset congenital thrombotic thrombocytopenic purpura
Luca A Lotta, Haifeng M Wu, Andrea Cairo, et al.
Haematologica
|
October 15, 2020
Dramatic presentation of acquired thombotic thrombocytopenic purpura associated with COVID-19
Marco Capecchi, Cristina Mocellin, Chiara Abbruzzese, et al.
Haematologica
|
April 12, 2003
Patients with localized and disseminated tumors have reduced but measurable levels of ADAMTS-13 (von Willebrand factor cleaving protease)
Pier Mannuccio Mannucci, Mehran Karimi, Ahmad Mosalaei, et al.
Thrombosis Research
|
May 27, 2015
Molecular characterization of 7 patients affected by dys- or hypo-dysfibrinogenemia: Identification of a novel mutation in the fibrinogen Bbeta chain causing a gain of glycosylation
Rosanna Asselta, Michela Robusto, Manuela Platé, et al.
Clinical Pharmacology and Therapeutics
|
March 6, 2004
CYP2C9 genotypes and dose requirements during the induction phase of oral anticoagulant therapy
Flora Peyvandi, Marta Spreafico, Simona Maria Siboni, et al.
Thrombosis Research
|
April 22, 2015
How the direct oral anticoagulant apixaban affects thrombin generation parameters
Armando Tripodi, Lidia Padovan, Chantarangkul Veena, et al.
Journal of Clinical Medicine Research
|
November 10, 2025
A Challenging Case of Immune-Related Organizing Pneumonitis Following Programmed Cell Death 1 Inhibitor Therapy in Non-Small Cell Lung Cancer
Giovanni Paolozzi, Roberta Gualtierotti, Raffaella Rossio, et al.
Journal of Thrombosis and Haemostasis : JTH
|
June 12, 2025
The genetic spectrum of rare bleeding disorders
Samin Mohsenian, Omid Seidizadeh, Andrea Cairo, et al.
Page
of 61